If I had to guess the sort of healthcare company that would get a premium acquisition offer, Lincare (Nasdaq:LNCR) would be low on my list, as relatively few buyers would want to pay a premium to get into a business that is beset by constant reimbursement pressures. But, as the old saying goes, you only need one buyer to make a deal and Lincare found that one.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

In a deal that reverses a spin-out from nearly 25 years ago, German industrial gases company Linde will be acquiring Lincare for $4.6 billion in total considerations. That works out to $41.50 per share for Lincare's shareholders; a 22% premium to Friday's closing price (which had been moving up on takeover rumors) and a whopping 67% premium to the stock's three-month average price.

SEE: Analyzing An Acquisition Announcement

What Is Linde Buying?
Linde is getting the nation's leading provider of in-home oxygen/respiratory therapy, with a national share of about 28%. Lincare has long been an exceptionally well-run company with strong management; management has built Lincare through a series of tuck-in acquisitions and has navigated the company through several challenging periods.

A lot of those challenges come from the nature of the business. Like home-care providers including Amedisys (Nasdaq:AMED) and LHC Group (Nasdaq:LHCG), Lincare gets a large amount of its revenue from the federal government - roughly 60% of the company's revenue comes from Medicare or Medicaid. With a large part of revenue subject to competitive bidding, a three-year limit on equipment rentals and ongoing rate cuts, the operating environment has been simply brutal of late.

SEE: Investing In The Healthcare Sector

And yet, Lincare has persevered. Lincare has managed to leverage its scale to drive down operating costs, and has repurchased roughly one-third of its shares over the past five years. At the same time, the company has tried to diversify away from its heavy dependence on oxygen therapy by building a specialty pharmaceutical business centered on anti-coagulation and pulmonary therapy.

Why Pay so Much?
To a certain extent, I can appreciate why Linde wants to expand its healthcare operations. The industrial gas business is very competitive and highly cyclical, and healthcare is a popular choice for companies looking to diversify (consider the example of Fujifilm). Moreover, other industrial gas companies like Air Products (NYSE:APD) and Praxair (NYSE:PX) have moved into the healthcare field to varying degrees (in fact, Linde bought Air Products' southern European healthcare business earlier this year).

SEE: Healthcare Funds: Give Your Portfolio A Booster Shot

All of that said, Linde is certainly paying a lot for this diversification. Lincare's market share is solid, and lends certain operating advantages, but it offers no respite to reimbursement pressures. Moreover, I find it hard to believe that there were competitive bidders forcing Linde to pay so much. As it stands, Linde is paying almost $10 (or 30%) more than I thought Lincare was worth, and the deal probably won't be materially additive until 2015 - and that's assuming there's no major downturn in reimbursement in the meanwhile.

The Bottom Line
Kudos to Lincare management for securing a great deal for its shareholders. To sell a Medicare-dependent business at a 25% premium to its all-time-high deserves more than just a pat on the back. Honestly, I cannot see why any Lincare shareholder wouldn't be thrilled with this deal.

I would not extrapolate this deal across the wider healthcare services group. True, there are quality names out there like AmSurg (Nasdaq:AMSG), Acadia Healthcare (Nasdaq:ACHC) and HCA (NYSE:HCA), and this bid from Linde proves that there's always a chance for a premium bid, but I just don't see a surplus of buyers willing to pay such high premiums today.

At the time of writing, Stephen D. Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Investing

    Build a Retirement Portfolio for a Different World

    When it comes to retirement rules of thumb, the financial industry is experiencing new guidelines and the new rules for navigating retirement.
  2. Investing

    Redefining the Stop-Loss

    Using Stop-losses for trading doesn’t mean ‘losing money’, but instead think about the money you'll start saving once you learn how they work.
  3. Fundamental Analysis

    10 Major Companies Tied to the Apple Supply Chain

    Apple has one of the best supply-chain models. Here are some of the top businesses involved, and the benefits and challenges for all.
  4. Term

    What are Non-GAAP Earnings?

    Non-GAAP earnings are a company’s earnings that are not reported according to Generally Accepted Accounting Principles.
  5. Mutual Funds & ETFs

    ETF Analysis: PowerShares FTSE RAFI US 1000

    Find out about the PowerShares FTSE RAFI U.S. 1000 ETF, and explore detailed analysis of the fund that invests in undervalued stocks.
  6. Options & Futures

    Use Options to Hedge Against Iron Ore Downslide

    Using iron ore options is a way to take advantage of a current downslide in iron ore prices, whether for producers or traders.
  7. Stock Analysis

    Fortinet: A Great Play on Cybersecurity

    Discover how a healthy product mix, large-business deal growth and the boom of the cybersecurity industry are all driving Fortinet profits.
  8. Stock Analysis

    2 Catalysts Driving Intrexon to All-Time Highs

    Examine some of the main reasons for Intrexon stock tripling in price between 2014 and 2015, and consider the company's future prospects.
  9. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  10. Charts & Patterns

    Understand How Square Works before the IPO

    Square is reported to have filed for an IPO. For interested investors wondering how the company makes money, Investopedia takes a look at its business.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Profit Margin

    A category of ratios measuring profitability calculated as net ...
  3. Quarter - Q1, Q2, Q3, Q4

    A three-month period on a financial calendar that acts as a basis ...
  4. Debt Ratio

    A financial ratio that measures the extent of a company’s or ...
  5. Price-Earnings Ratio - P/E Ratio

    The Price-to-Earnings Ratio or P/E ratio is a ratio for valuing ...
  6. Net Present Value - NPV

    The difference between the present values of cash inflows and ...
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the formula for calculating compound annual growth rate (CAGR) in Excel?

    The compound annual growth rate, or CAGR for short, measures the return on an investment over a certain period of time. Below ... Read Full Answer >>
  3. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  4. When does the fixed charge coverage ratio suggest that a company should stop borrowing ...

    Since the fixed charge coverage ratio indicates the number of times a company is capable of making its fixed charge payments ... Read Full Answer >>
  5. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  6. What is the difference between the return on total assets and an interest rate?

    Return on total assets (ROTA) represents one of the profitability metrics. It is calculated by taking a company's earnings ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!